D Katsaros

1.2k total citations
16 papers, 1.0k citations indexed

About

D Katsaros is a scholar working on Oncology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, D Katsaros has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Cancer Research. Recurrent topics in D Katsaros's work include Ovarian cancer diagnosis and treatment (5 papers), Cancer, Lipids, and Metabolism (2 papers) and Immune Cell Function and Interaction (2 papers). D Katsaros is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Cancer, Lipids, and Metabolism (2 papers) and Immune Cell Function and Interaction (2 papers). D Katsaros collaborates with scholars based in Italy, United States and Canada. D Katsaros's co-authors include George Coukos, Phyllis A. Gimotty, Ronald J. Buckanovich, Dimitra Sasaroli, Andrea Facciabene, Klara Balint, Fabián Benencia, Sarah Kim-Hellmuth, S. Fracchioli and Andreas Scorilas and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

D Katsaros

16 papers receiving 988 citations

Peers

D Katsaros

ONCOL

IMMUN

GENET

Yvonne T.M. Tsang United States

Gunnar Wrobel Germany

D.S. Dimitrov United States

Hong-Ji Xu United States

Frederick Racke United States

José La Rose Canada

Simone Anfossi United States

Sigitas Verselis United States

Audrey Rapinat France

A. Reza Radjabi United States

Yvonne T.M. Tsang United States

D Katsaros

329 ×0.6

ONCOL

533 ×1.4

166 ×0.5

IMMUN

148 ×0.8

GENET

211 ×1.2

Citations per year, relative to D Katsaros D Katsaros (= 1×) peers Yvonne T.M. Tsang

Countries citing papers authored by D Katsaros

Since Specialization

Citations

This map shows the geographic impact of D Katsaros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Katsaros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Katsaros more than expected).

Fields of papers citing papers by D Katsaros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Katsaros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Katsaros. The network helps show where D Katsaros may publish in the future.

Co-authorship network of co-authors of D Katsaros

This figure shows the co-authorship network connecting the top 25 collaborators of D Katsaros. A scholar is included among the top collaborators of D Katsaros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Katsaros. D Katsaros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lu, Lingeng, et al.. (2013). An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival. Carcinogenesis. 34(9). 2024–2030. 29 indexed citations

Scambia, Giovanni, Gabriella Parma, Dagmar Hess, et al.. (2008). A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens. Journal of Clinical Oncology. 26(15_suppl). 5581–5581. 2 indexed citations

Gimotty, Phyllis A., Lin Zhang, Mark G. Cadungog, et al.. (2007). Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research. Disease Markers. 23(5-6). 445–452. 4 indexed citations

Buckanovich, Ronald J., Andrea Facciabene, Sarah Kim-Hellmuth, et al.. (2007). Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Medicine. 14(1). 28–36. 430 indexed citations

Zhang, Lin, Jia Huang, Nuo Yang, et al.. (2007). MICRORNAS EXHIBIT HIGH FREQUENCY GENO-MIC ALTERATIONS IN HUMAN OVARIAN CANCER. Biology of Reproduction. 77(Suppl_1). 66–66. 1 indexed citations

Buckanovich, Ronald J., Dimitra Sasaroli, Jeffrey Botbyl, et al.. (2007). Tumor Vascular Proteins As Biomarkers in Ovarian Cancer. Journal of Clinical Oncology. 25(7). 852–861. 161 indexed citations

Fracchioli, S., Irene A. Rigault de la Longrais, Fabrizio Bogliatto, et al.. (2006). Primary “breast-like” cancer of the vulva: a case report and critical review of the literature. International Journal of Gynecological Cancer. 16(S1). 423–428. 33 indexed citations

Katsaros, D, Irene A. Rigault de la Longrais, Annamaria Ferrero, et al.. (2005). Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma. Annals of Oncology. 16(2). 300–306. 20 indexed citations

Porpiglia, Mauro, Antonio Durando, S. Fracchioli, et al.. (2004). [Biologic therapy and epithelial ovarian cancer].. PubMed. 56(1). 91–104. 1 indexed citations

10.

Katsaros, D, M Massobrio, G. Regnani, et al.. (2003). Intratumoral T cells and survival in epithelial ovarian cancer. 1 indexed citations

11.

Piccinno, R., et al.. (2002). [Growth factors in epithelial ovarian cancer].. PubMed. 54(1). 33–52. 3 indexed citations

12.

Obiezu, Christina V., Andreas Scorilas, D Katsaros, et al.. (2001). Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.. PubMed. 7(8). 2380–6. 108 indexed citations

13.

Magklara, Angeliki, Andreas Scorilas, D Katsaros, et al.. (2001). The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.. PubMed. 7(4). 806–11. 117 indexed citations

14.

Bellino, R, Silvio Danese, Antonio Durando, et al.. (2001). Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.. PubMed. 20(6C). 4825–8. 9 indexed citations

15.

Katsaros, D, Elisabeth G.E. de Vries, M Massobrio, et al.. (1999). Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.. PubMed. 5(10). 2798–805. 91 indexed citations

16.

Zarghami, Nosratollah, et al.. (1995). Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma.. PubMed. 5(3). 401–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact